4//SEC Filing
LeCointe-Cephas Lisa 4
Accession 0001127602-23-014206
CIK 0000310158other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 3:11 PM ET
Size
8.5 KB
Accession
0001127602-23-014206
Insider Transaction Report
Form 4
LeCointe-Cephas Lisa
SVP Chief Ethics & Com Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-01$115.47/sh+643$74,247→ 4,375.693 total - Tax Payment
Common Stock
2023-05-01$115.47/sh−221$25,519→ 4,154.693 total - Exercise/Conversion
Restricted Stock Unit
2023-05-01−643→ 0 totalFrom: 2021-05-01Exp: 2023-05-01→ Common Stock (643 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001854644
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 3:11 PM ET
- Size
- 8.5 KB